RxSight, Inc. (NASDAQ: RXST) reported Q1 EPS of ($0.19), $0.12 better than the analyst estimate of ($0.31). Revenue for the quarter came in at $30.9 million versus the consensus estimate of $29.75 million.

For earnings history and earnings-related data on RxSight, Inc. (RXST) click here.